EUVIMEDEUVIMED entdecken
Open Access

Inhibition of CaV1.4 channels by CaV3 channel antagonists ML218 and Z944

Jinglang Sun iD, Juan de la Rosa Vázquez iD, Adriana Hernández-González iD, Vladimir Yarov-Yarovoy iD, Amy Lee iD

Journal of General Physiology · 2026

DOI: 10.1085/jgp.202513879 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of General Physiology, 2026. Verfasst von Jinglang Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience and Center for Learning and Memory, The University of Texas at Austin, Austin, TX, USA. Hauptthemen laut MEDLINE: Calcium Channel Blockers, Calcium Channels, T-Type. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NCATS NIH HHS, NEI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Among the three classes of voltage-gated Ca2+ channels (CaV1, CaV2, and CaV3), CaV3 T-type channels are drug targets for disorders, including epilepsy and pain. Antagonists such as Z944 and ML218 are highly selective for CaV3 compared with the CaV1.2 L-type channel, but whether they have additional activity on other CaV1 subtypes is unknown. Here, we investigated the effects of Z944 and ML218 on the CaV1.4 channel, which regulates neurotransmitter release from retinal photoreceptors. In HEK293T cells transfected with CaV1.4 and the auxiliary β2x13 and α2δ-4 subunits, Z944 and ML218 inhibited Ca2+ currents with IC50 values of ∼30 and 2 µM, respectively. Structure-based modeling combined with functional studies revealed the importance of a cluster of methionine residues, particularly M1004, within the DHP-binding site for the effects of ML218. Compared with mutation of a conserved threonine (T1007) that is required for DHP sensitivity of CaV1 channels, mutation of M1004 had a 10-fold greater impact in diminishing the potency of ML218. CaV1.2 was significantly less sensitive to ML218 inhibition (IC50 ∼37 µM) than CaV1.4, which could not be attributed to a valine in place of M1004 in CaV1.2. We conclude that ML218 and Z944 are dual CaV1/CaV3 modulators of CaV1.4 and should be used with caution when dissecting the contributions of CaV3 channels in tissues where CaV1.4 is expressed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Calcium Channel BlockersCalcium Channels, T-TypeHumansHEK293 CellsAnimalsCaveolin 3

Substanzen

Calcium Channel BlockersCalcium Channels, T-TypeCAV3 protein, humanCaveolin 3

Autor:innen und Institutionen

  • Department of Neuroscience and Center for Learning and Memory, The University of Texas at Austin, Austin, TX, USA.
  • Department of Physiology and Membrane Biology, University of California, Davis, Davis, CA, USA.
  • Department of Anesthesiology and Pain Medicine, University of California, Davis, Davis, CA, USA.

ORCID-Profile: Jinglang Sun, Juan de la Rosa Vázquez, Adriana Hernández-González, Vladimir Yarov-Yarovoy, Amy Lee

Förderung

  • NIH HHS
  • NCATS NIH HHS
  • NEI NIH HHS
  • Karl Folkers Chair in Interdisciplinary Biomedical Research
  • NHLBI NIH HHS
  • National Institutes of Health

Zitieren

APA

Sun, J., de la Rosa Vázquez, J., Hernández-González, A., Yarov-Yarovoy, V., & Lee, A. (2026). Inhibition of CaV1.4 channels by CaV3 channel antagonists ML218 and Z944. Journal of General Physiology. https://doi.org/10.1085/jgp.202513879

Vancouver

Sun J, de la Rosa Vázquez J, Hernández-González A, Yarov-Yarovoy V, Lee A. Inhibition of CaV1.4 channels by CaV3 channel antagonists ML218 and Z944. Journal of General Physiology. 2026. doi:10.1085/jgp.202513879

BibTeX
@article{Sun2026,
  author = {Sun, Jinglang and de la Rosa Vázquez, Juan and Hernández-González, Adriana and Yarov-Yarovoy, Vladimir and Lee, Amy},
  title = {Inhibition of CaV1.4 channels by CaV3 channel antagonists ML218 and Z944},
  journal = {Journal of General Physiology},
  year = {2026},
  doi = {10.1085/jgp.202513879}
}
Kostenlos starten →